Oseltamivir-resistant influenza A(H1N1)pdm09 virus in Dutch travellers returning from Spain, August 2012

Eurosurveillance

Volumn 17, Issue 36, 2012, Pages

  Meijer, A ^a   Jonges, M ^a   van Beek, P ^a   Swaan, C M ^a   Osterhaus, A D ^b   Daniels, R S ^c   Hurt, A C ^c   Koopmans, M P ^a,b  

^a NATIONAL INSTITUTE FOR PUBLIC HEALTH AND THE ENVIRONMENT   (Netherlands)

^b ERASMUS MEDICAL CENTER   (Netherlands)

^c WORLD HEALTH ORGANIZATION   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

HEMAGGLUTININ; OSELTAMIVIR; SIALIDASE;

ADULT; AMINO ACID SUBSTITUTION; ARTICLE; CASE REPORT; COUGHING; EMPORIATRICS; FEVER; GENE MUTATION; GENETIC ANALYSIS; HUMAN; INFLUENZA A (H1N1); INFLUENZA VIRUS A H1N1; INFLUENZA VIRUS A H1N1 PDM09; MALAISE; MALE; PHYLOGENY; SEQUENCE ANALYSIS; SPAIN;

EID: 84866434839     PISSN: 1025496X     EISSN: 15607917     Source Type: Journal    
DOI: None     Document Type: Article

References (23)

1. Yen HL, Herlocher LM, Hoffmann E, Matrosovich MN, Monto AS, Webster RG, et al. Neuraminidase inhibitor-resistant influenza viruses may differ substantially in fitness and transmissibility. Antimicrob Agents Chemother. 2005;49(10):4075-84.
2. Monto AS, McKimm-Breschkin JL, Macken C, Hampson AW, Hay A, Klimov A, et al. Detection of influenza viruses resistant to neuraminidase inhibitors global surveillance during the first 3 years of their use. Antimicrob Agents Chemother. 2006;50(7):2395-402.
3. Sheu TG, Deyde VM, Okomo-Adhiambo M, Garten RJ, Xu X, Bright RA, et al. Surveillance for neuraminidase inhibitor resistance among human influenza A and B viruses circulating worldwide from 2004 to 2008. Antimicrob Agents Chemother. 2008;52(9):3284-92.
4. Meijer A, Lackenby A, Hay A, Zambon M. Influenza antiviral susceptibility monitoring activities in relation to national antiviral stockpiles in Europe during the winter 2006/2007 season. Euro Surveill. 2007;12 (4):pii=698. Available from: http://www.eurosurveillance.org/ViewArticle. aspx?ArticleId=698
5. Jonges M, van der Lubben IM, Dijkstra F, Verhoef L, Koopmans M, Meijer A. Dynamics of antiviral-resistant influenza viruses in the Netherlands, 2005-2008. Antiviral Res. 2009;83(3):290-7.
6. Lackenby A, Hungnes O, Dudman SG, Meijer A, Paget WJ, Hay AJ, et al. Emergence of resistance to oseltamivir among influenza A(H1N1) viruses in Europe. Euro Surveill. 2008;13(5):pii=8026. Available from: http://www. eurosurveillance.org/ViewArticle.aspx?ArticleId=8026
7. Hauge SH, Dudman S, Borgen K, Lackenby A, Hungnes O. Oseltamivir-resistant influenza viruses A (H1N1), Norway, 2007-08. Emerg Infect Dis. 2009;15(2):155-62.
8. Meijer A, Lackenby A, Hungnes O, Lina B, van-der-Werf S, Schweiger B, et al. Oseltamivir-resistant influenza virus A (H1N1), Europe, 2007-08 season. Emerg Infect Dis. 2009;15(4):552-60.
9. Dharan NJ, Gubareva LV, Meyer JJ, Okomo-Adhiambo M, McClinton RC, Marshall SA, et al. Oseltamivir-Resistance Working Group. Infections with oseltamivir-resistant influenza A(H1N1) virus in the United States. JAMA. 2009;301(10):1034-41.
10. García J, Sovero M, Torres AL, Gomez J, Douce R, Barrantes M, et al. Antiviral resistance in influenza viruses circulating in Central and South America based on the detection of established genetic markers. Influenza Other Respi Viruses. 2009;3(2):69-74.
11. Hurt AC, Ernest J, Deng YM, Iannello P, Besselaar TG, Birch C, et al. Emergence and spread of oseltamivir-resistant A(H1N1) influenza viruses in Oceania, South East Asia and South Africa. Antiviral Res. 2009;83(1):90-3.
12. Meijer A, Jonges M, Abbink F, Ang W, van Beek J, Beersma M, et al. Oseltamivir-resistant pandemic A(H1N1) 2009 influenza viruses detected through enhanced surveillance in the Netherlands, 2009-2010. Antiviral Res. 2011;92(1):81-9.
13. Hurt AC, Chotpitayasunondh T, Cox NJ, Daniels R, Fry AM, Gubareva LV, et al. WHO Consultation on Pandemic Influenza A (H1N1) 2009 Virus Resistance to Antivirals. Antiviral resistance during the 2009 influenza A H1N1 pandemic: public health, laboratory, and clinical perspectives. Lancet Infect Dis. 2012;12(3):240-8.
14. Lackenby A, Moran Gilad J, Pebody R, Miah S, Calatayud L, Bolotin S, et al. Continued emergence and changing epidemiology of oseltamivir-resistant influenza A(H1N1)2009 virus, United Kingdom, winter 2010/11. Euro Surveill. 2011;16(5);pii:=19784. Available from: http://www. eurosurveillance.org/ViewArticle.aspx?ArticleId=19784
15. Hurt AC, Hardie K, Wilson NJ, Deng YM, Osbourn M, Leang SK, et al. Characteristics of a widespread community cluster of H275Y oseltamivir-resistant A(H1N1)pdm09 influenza in Australia. J Infect Dis. 2012;206(2):148-57.
16. Storms AD, Gubareva LV, Su S, Wheeling JT, Okomo-Adhiambo M, Pan CY, et al. Oseltamivir-resistant pandemic (H1N1) 2009 virus infections, United States, 2010-11. Emerg Infect Dis. 2012;18(2):308-11.
17. Dijkstra F, Jonges M, van Beek R, Donker GA, Schellevis FG, Koopmans M, et al. Influenza A(H1N1) Oseltamivir Resistant Viruses in the Netherlands During the Winter 2007/2008. Open Virol J. 2011;5:154-62.
18. van der Vries E, Jonges M, Herfst S, Maaskant J, Van der Linden A, Guldemeester J, et al. Evaluation of a rapid molecular algorithm for detection of pandemic influenza A (H1N1) 2009 virus and screening for a key oseltamivir resistance (H275Y) substitution in neuraminidase. J Clin Virol. 2010;47(1):34-7.
19. Cao B, Li XW, Mao Y, Wang J, Lu HZ, Chen YS, et al. National Influenza A Pandemic (H1N1) 2009 Clinical Investigation Group of China. Clinical features of the initial cases of 2009 pandemic influenza A (H1N1) virus infection in China. N Engl J Med. 2009;361(26):2507-17.
20. Fry AM, Gubareva LV. Understanding influenza virus resistance to antiviral agents; early warning signs for wider community circulation. J Infect Dis. 2012;206(2):145-7.
21. Wang B, Taylor J, Ratnamohan M, McPhie K, Kesson A, Dixit R, et al. Frequency of oseltamivir resistance in Sydney, during the Newcastle outbreak of community transmitted oseltamivir-resistant influenza A(H1N1)pdm09 virus, Australia, June to August 2011. Euro Surveill. 2012;17(27):pii=20210. Available from: http://www.eurosurveillance.org/ViewArticle. aspx?ArticleId=20210
22. Chao DL, Bloom JD, Kochin BF, Antia R, Longini IM Jr. The global spread of drug-resistant influenza. J R Soc Interface. 2012;9(69):648-56.
23. Bloom JD, Gong LI, Baltimore D. Permissive secondary mutations enable the evolution of influenza oseltamivir resistance. Science. 2010;328(5983):1272-5.